{
  "ticker": "LH",
  "year": 2023,
  "quarter": 2,
  "last_updated": "2025-04-15T14:53:27.739286",
  "count": 3,
  "transactions": [
    {
      "id": 90087,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "van der Vaart Sandra D",
      "reporting_owner_cik": "0001537208",
      "reporting_owner_position": "EVP, Chief Legal Officer",
      "transaction_date": "2023-06-29",
      "transaction_shares": "212",
      "transaction_price": "240.00",
      "transaction_type": "S",
      "shares_after_transaction": "7604.6975"
    },
    {
      "id": 90049,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Kirchgraber Paul R",
      "reporting_owner_cik": "0001791393",
      "reporting_owner_position": "CEO, Covance Drug Development",
      "transaction_date": "2023-05-19",
      "transaction_shares": "4300",
      "transaction_price": "182.51",
      "transaction_type": "M",
      "shares_after_transaction": "17246"
    },
    {
      "id": 90042,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schroeder Mark S",
      "reporting_owner_cik": "0001793112",
      "reporting_owner_position": "EVP, Pres Diagnostics & COO",
      "transaction_date": "2023-05-18",
      "transaction_shares": "1500",
      "transaction_price": "130.60",
      "transaction_type": "M",
      "shares_after_transaction": "8187.4022"
    }
  ]
}